Gerard J. Davis

434 total citations
21 papers, 371 citations indexed

About

Gerard J. Davis is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerard J. Davis has authored 21 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerard J. Davis's work include Protease and Inhibitor Mechanisms (6 papers), Peptidase Inhibition and Analysis (5 papers) and Genetic factors in colorectal cancer (3 papers). Gerard J. Davis is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Peptidase Inhibition and Analysis (5 papers) and Genetic factors in colorectal cancer (3 papers). Gerard J. Davis collaborates with scholars based in United States, United Kingdom and Denmark. Gerard J. Davis's co-authors include Antony M. Wheatley, Edward J. Johns, Cheuk‐Kwan Sun, Xingyi Zhang, Fayez T. Hammad, Hans Jørgen Nielsen, Barry L. Dowell, Ib Jarle Christensen, William Bosron and Thomas D. Hurley and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Gerard J. Davis

19 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerard J. Davis United States 11 86 81 81 77 65 21 371
Arthur M. Magun United States 9 77 0.9× 123 1.5× 99 1.2× 60 0.8× 42 0.6× 14 391
Anat Shriki Israel 7 67 0.8× 116 1.4× 84 1.0× 76 1.0× 38 0.6× 8 451
Yosuke Horita Japan 11 104 1.2× 81 1.0× 148 1.8× 36 0.5× 66 1.0× 46 436
Geoffrey Ibbotson United States 9 98 1.1× 71 0.9× 55 0.7× 89 1.2× 24 0.4× 15 549
Hidetoshi Satoh Japan 9 95 1.1× 136 1.7× 68 0.8× 37 0.5× 29 0.4× 18 424
K Mori Japan 9 135 1.6× 40 0.5× 73 0.9× 68 0.9× 85 1.3× 26 367
Chunhua Lin China 11 119 1.4× 176 2.2× 63 0.8× 191 2.5× 58 0.9× 33 491
Fujio Matsumura Japan 12 167 1.9× 60 0.7× 86 1.1× 67 0.9× 90 1.4× 28 396
Sigrun Badrnya Austria 10 93 1.1× 196 2.4× 90 1.1× 69 0.9× 42 0.6× 16 593
Takahiro Tabata Japan 11 78 0.9× 122 1.5× 56 0.7× 80 1.0× 21 0.3× 16 412

Countries citing papers authored by Gerard J. Davis

Since Specialization
Citations

This map shows the geographic impact of Gerard J. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard J. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard J. Davis more than expected).

Fields of papers citing papers by Gerard J. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard J. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard J. Davis. The network helps show where Gerard J. Davis may publish in the future.

Co-authorship network of co-authors of Gerard J. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard J. Davis. A scholar is included among the top collaborators of Gerard J. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard J. Davis. Gerard J. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farnsworth, Christopher W, John C. Prostko, Gerard J. Davis, et al.. (2025). Systemic inflammation is associated with worse outcomes from SARS-CoV-2 infection but not neutralizing antibody. Microbiology Spectrum. 13(4). e0245924–e0245924. 1 indexed citations
2.
Nielsen, Hans Jørgen, Jon J. Ladd, Paul D. Lampe, et al.. (2020). 909 DEVELOPMENT OF BLOOD-BASED BIOMARKER TESTS FOR EARLY DETECTION OF COLORECTAL NEOPLASIA: INFLUENCE OF BLOOD COLLECTION TIMING AND HANDLING PROCEDURES. Gastroenterology. 158(6). S–1542. 1 indexed citations
4.
Bresalier, Robert S., James C. Byrd, Dean E. Brenner, et al.. (2017). A Blood-Based Marker Panel for Detection of Colorectal Neoplasia. Gastroenterology. 152(5). S1316–S1316. 1 indexed citations
5.
Christensen, Ib Jarle, Nils Brünner, Barry L. Dowell, et al.. (2015). Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.. PubMed. 35(9). 4935–41. 24 indexed citations
6.
Bass, Michael, Bin Yao, Yong-Jiang Hei, et al.. (2014). Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience. PLoS ONE. 9(10). e108048–e108048. 5 indexed citations
7.
Harrison, Joanne C., et al.. (2014). Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy. American Journal of Physiology-Renal Physiology. 307(3). F251–F262. 22 indexed citations
8.
Lottenburger, Tine, Gerard J. Davis, Barry L. Dowell, et al.. (2008). Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1. The International Journal of Biological Markers. 23(1). 42–47. 22 indexed citations
9.
Lottenburger, Tine, Gerard J. Davis, Barry L. Dowell, et al.. (2008). Assessment of the Biological Variation of Plasma Tissue Inhibitor of Metalloproteinases-1. The International Journal of Biological Markers. 23(1). 42–47. 19 indexed citations
10.
Blincko, Stuart, Vibeke Jensen, Hans Jørgen Nielsen, et al.. (2006). Evaluation of an Improved Tissue Inhibitor of Metalloproteinase 1 Dual Monoclonal Sandwich Immunoassay. Tumor Biology. 27(6). 319–328.
11.
Dowell, Barry L., Kent D. Stewart, Vibeke Jensen, et al.. (2005). Establishment and Characterization of 7 New Monoclonal Antibodies to Tissue Inhibitor of Metalloproteinases-1. Tumor Biology. 26(2). 71–80. 23 indexed citations
12.
Sun, Cheuk‐Kwan, et al.. (2001). EFFECT OF ISCHEMIA-REPERFUSION INJURY ON THE MICROCIRCULATION OF THE STEATOTIC LIVER OF THE ZUCKER RAT1. Transplantation. 72(10). 1625–1631. 93 indexed citations
13.
Hammad, Fayez T., Antony M. Wheatley, & Gerard J. Davis. (2000). Long-term renal effects of unilateral ureteral obstruction and the role of endothelin. Kidney International. 58(1). 242–250. 42 indexed citations
14.
Davis, Gerard J., et al.. (1997). Expression and Purification of Recombinant Rhinovirus 14 3CD Proteinase and Its Comparison to the 3C Proteinase. Archives of Biochemistry and Biophysics. 346(1). 125–130. 16 indexed citations
15.
Davis, Gerard J., et al.. (1996). X-ray Structure of Human β3β3 Alcohol Dehydrogenase. Journal of Biological Chemistry. 271(29). 17057–17061. 38 indexed citations
16.
Davis, Gerard J. & Edward J. Johns. (1995). Renal sympathetic nerve responses to somato-sensory nerve stimulation in normotensive rats. Journal of the Autonomic Nervous System. 54(1). 59–70. 12 indexed citations
17.
Davis, Gerard J., et al.. (1994). Effect of nitrendipine on autoregulation of perfusion in the cortex and papilla of kidneys from Wistar and stroke prone spontaneously hypertensive rats. British Journal of Pharmacology. 111(1). 111–116. 15 indexed citations
18.
Davis, Gerard J., et al.. (1993). Role of Haematocrit in Mediating the Actions of Chronic Erythropoietin Treatment on Blood Pressure and Renal Haemodynamics in the Rat. Clinical Science. 85(6). 717–724. 10 indexed citations
19.
Davis, Gerard J., et al.. (1992). Study of the actions of human recombinant erythropoietin on rat renal haemodynamics. Clinical Science. 83(4). 453–459. 8 indexed citations
20.
Davis, Gerard J. & Edward J. Johns. (1990). The effect of angiotensin II and vasopressinonrenal haemodynamics. Journal of Medical Engineering & Technology. 14(5). 197–200. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026